NEUROSTEM Trademark

Trademark Overview

On Monday, April 28, 2014, a trademark application was filed for NEUROSTEM with the United States Patent and Trademark Office. The USPTO has given the NEUROSTEM trademark a serial number of 86264093. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 17, 2021. This trademark is owned by MEDIPOST CO., LTD.. The NEUROSTEM trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations, namely, tissue cultures for medical or veterinary purposes; pharmaceutical preparations for treatment of cancer, for the treatment of central nervous system disorders, for central nerve treatment, for treatment of tumors, for activating cellular function, for immunity adjustment and for treatment of autoimmune disease; biological preparations for medical purposes, namely, for treatment of cancer, for the treatment of central nervous system disorders, for central nerve treatment, for treatment of tumors, for activating cellular function, for immunity adjustment and for treatment of autoimmune disease; diagnostic reagents for medicinal use; capsules sold empty for medicines; medicament formulating agents, namely, medicaments to help assist with the regeneration of ligament and tendon fibers; vaccine; bouillons for bacteriological cultures
neurostem

General Information

Serial Number86264093
Word MarkNEUROSTEM
Filing DateMonday, April 28, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 17, 2021
Registration Number4757772
Registration DateTuesday, June 16, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesBiological preparations, namely, tissue cultures for medical or veterinary purposes; pharmaceutical preparations for treatment of cancer, for the treatment of central nervous system disorders, for central nerve treatment, for treatment of tumors, for activating cellular function, for immunity adjustment and for treatment of autoimmune disease; biological preparations for medical purposes, namely, for treatment of cancer, for the treatment of central nervous system disorders, for central nerve treatment, for treatment of tumors, for activating cellular function, for immunity adjustment and for treatment of autoimmune disease; diagnostic reagents for medicinal use; capsules sold empty for medicines; medicament formulating agents, namely, medicaments to help assist with the regeneration of ligament and tendon fibers; vaccine; bouillons for bacteriological cultures

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMEDIPOST CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressSeocho-gu, Seoul 137-874
KR
Party NameMEDIPOST CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSeocho-gu, Seoul 137-874
KR

Trademark Events

Event DateEvent Description
Friday, December 17, 2021CANCELLED SEC. 8 (6-YR)
Tuesday, June 16, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 12, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Tuesday, May 5, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, May 5, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 5, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, May 5, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, May 5, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, May 5, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 5, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, June 16, 2015REGISTERED-SUPPLEMENTAL REGISTER
Wednesday, May 13, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, May 12, 2015APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Tuesday, May 12, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, May 12, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 12, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, May 12, 2015EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 1, 2015NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, April 1, 2015FINAL REFUSAL E-MAILED
Wednesday, April 1, 2015FINAL REFUSAL WRITTEN
Wednesday, March 11, 2015PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Sunday, March 8, 2015TEAS VOLUNTARY AMENDMENT RECEIVED
Monday, March 9, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 9, 2015LETTER OF SUSPENSION E-MAILED
Monday, March 9, 2015SUSPENSION LETTER WRITTEN
Tuesday, February 17, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 6, 2015ASSIGNED TO LIE
Thursday, January 29, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 11, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 11, 2014NON-FINAL ACTION E-MAILED
Monday, August 11, 2014NON-FINAL ACTION WRITTEN
Monday, August 11, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 11, 2014NON-FINAL ACTION E-MAILED
Monday, August 11, 2014NON-FINAL ACTION WRITTEN
Monday, August 11, 2014ASSIGNED TO EXAMINER
Monday, May 12, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 1, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

neurostem treatment central namely preparations activating nerve cellular tumors immunity disease